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Abstract
Rationale: Rigid bronchoscopy–guided (RBG) percutaneous
tracheostomy has been used in patients with morbid obesity,
prior neck surgery, distorted airway anatomy, and uncorrected
coagulopathy where standard percutaneous dilational
tracheostomy (PDT) is relatively contraindicated.
Objectives: This study aims to describe a standardized
approach to incorporate RBG-PDT in clinical practice.
Methods and Measurements: Retrospective case series of
patients who underwent RBG-PDT from 2008 to 2012 at Beth
Israel Deaconess Medical Center. Patient medical records
were reviewed for demographics, comorbid conditions,
American Society of Anesthesiologists classiﬁcation, indication
for tracheostomy, duration of procedure, and periprocedural
complications.
Main Results: A total of 35 patients underwent RBG-PDT,
including 24 men, with a mean age of 66 years (611 yr; range,
42–88 yr). The mean body mass index was 34 kg/m2. The
mean procedure time was 32 (610) minutes, with a median
of 33 minutes. The most common indication for tracheostomy
was failure to wean from mechanical ventilation, followed
by tracheal stenosis and tracheobronchomalacia. The most
common indications for RBG-PDT were complex airway,
obesity, and coagulopathy. There were no periprocedural
complications of consequence, or mortality associated with
the procedure.
Conclusions: RBG-PDT is safe and effective in a population
of high-risk patients who are otherwise not considered good
candidates for standard PDT.
Keywords: airway management; tracheostomy; respiratory
insufﬁciency
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Tracheostomy is one of the most commonly
performed procedures in the intensive
care unit (ICU) (1, 2). Since the
introduction of percutaneous dilational
tracheostomy (PDT) technique in 1985,
substantial advances have been made,
resulting in improved safety and ease of
the procedure (3). Over the past
decade, the application of various
imaging guidance modalities (ﬂexible
bronchoscopy, rigid bronchoscopy,
and ultrasound) has further enhanced
PDT and extended its use in a variety
of patient populations (4, 5).
In a recent European study, the
majority of ICU physicians (73%) prefer
to use PDT as the procedure of choice for
elective tracheostomy in the ICU population
requiring long-term ventilation (6). A
meta-analysis examining a pool of 1,000
patients noted several outcome differences
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between surgical tracheostomy and PDT
(7). Notably, there were fewer stomal
wound infections, smaller neck scars,
shorter procedural time, and reduction in
cost with PDT. There were no signiﬁcant
differences in mortality, false passage
creation, minor or major hemorrhage, or
development of late subglottic stenosis
between the techniques (3, 4, 7–11).
PDT is easily performed through the
use of the ﬂexible or the rigid bronchoscope.
However, unlike the rigid bronchoscope,
the ﬂexible bronchoscope does not provide
a secure airway, can be damaged, does
not provide protection to the posterior
tracheal membrane, has limited suction
capability, and obstructs the endotracheal
tube, which may interfere with adequate
ventilation. The use of rigid bronchoscopy
in PDT has not been adequately described.
In a review of the literature, only one
case series of seven patients using rigid
bronchoscopy has been reported (8). Thus,
a more in-depth evaluation of the use of
rigid bronchoscopy–guided (RBG) PDT to
assess the utility, practicality, and safety
proﬁle is needed. Here, we present our
experience in the use of RBG-PDT at our
institution in patients considered at high
risk for percutaneous tracheostomy. Some
of the results of our study have been
previously reported in abstract form (12)
and were presented at the May 2012
American Thoracic Society meeting in
San Francisco.
Methods
Study Design and Patient Selection
We retrospectively collected all consecutive
patients who underwent RGB-PDT from
January 2008 to December 2012. The study
protocol was approved by the institutional
review board at Beth Israel Deaconess
Medical Center, Boston, Massachusetts
(Protocol 2011-P-000186).
The Beth Israel Deaconess Medical
Center is a tertiary-care academic facility,
with a medical, surgical, trauma, cardiac,
cardiothoracic, and neurologic ICU, and
has a large general medical and surgical
service.
We included all adult patients,
18 years or older, who suffered from acute
respiratory failure requiring endotracheal
intubation and mechanical ventilation,
and were selected for tracheostomy
placement under rigid bronchoscopy
guidance for prolonged respiratory failure
and failure to wean from mechanical
ventilation. Patient medical records were
reviewed for general demographics,
comorbid medical conditions, American
Society of Anesthesiology classiﬁcation,
indication for tracheostomy (speciﬁcally
for RBG-PDT), duration of procedure,
and periprocedural complications. High-
risk features, such as morbid obesity,
coagulopathy, complex airway and prior
neck surgery, were used for patient selection.
RBG-PDT
RBG-PDT is an elective procedure in
our institution for medical and surgical
patients with respiratory failure requiring
tracheostomy to receive prolongedmechanical
ventilatory support. Interventional
pulmonologists and thoracic surgeons
performed all the RBG-PDT procedures.
All RBG-PDTs were performed in the
operating room under general anesthesia
and were monitored with continuous
recording for heart rate, respiratory rate,
blood pressure, oxygen saturation, and
cardiac rhythm. Mechanical ventilation
was maintained with fraction of inspired
oxygen at 1.0 and jet ventilation.
After informed consent was obtained,
the patient was brought to the operating
room and placed in the supine position.
A towel roll was placed between the scapulae
to extend the neck. A 12-mm outer diameter
rigid tracheoscope (Bryan-Dumon, Bryant
Corp., Woburn, MA) was introduced
orally (Figure 1A) and advanced to the
posterior pharynx until the vocal cords
were visualized. At that point, the rigid
barrel was advanced to the glottis with the
bevel anteriorly. The tip of the barrel was
positioned 5 mm distal to the true vocal
cords, and care was exercised to avoid
displacement of the rigid barrel while
removing the endotracheal tube from the
airway (Figure 1B). The rigid tracheoscope
was advanced into the subglottic area
and was used to provide jet ventilation,
continuous suction, and visual guidance
for the remainder of the procedure
(Figure 1C). After completing the exchange
of the endotracheal tube for the rigid
bronchoscope, the thyroid and cricoid
cartilages were palpated. The tracheal rings
could also be palpated and a mark was
made at the second intercartilaginous space.
The skin was prepped in the usual sterile
fashion, and 10 ml of lidocaine (1.5%)
with epinephrine (1:200,000 dilution) was
used to anesthetize the skin and
subcutaneous tissue. A 1-cm horizontal
or vertical incision was performed.
Through the incision, the Kelly clamp was
used to dissect through the subcutaneous
tissue to the anterior tracheal wall. At
this point, the ﬁnder needle was introduced
through the trachea and into the airway,
and position was conﬁrmed under
bronchoscopic guidance. The guiding
angiocath was then inserted between the
second and third cartilaginous rings under
bronchoscopic visualization. The needle
was removed and the guide wire was
introduced through the angiocath, followed
by withdrawal of the angiocath. A punch
dilator was introduced over the guide
wire followed by the Blue Rhino (Cook
Critical Care, Bloomington, IN) tapered
dilator, which dilated the tracheal stoma.
Then, a no. 7 or no. 8 Portex tracheostomy
tube (Portex Per-ﬁt; Smiths Medical,
Dublin, OH) was introduced onto a dilator
and advanced into the trachea. Both the
dilator and wire were withdrawn, and the
tracheostomy tube was secured in place
with 2-0 Prolene sutures (Prolypropylene
Suture, ETHICON; Johnson & Johnson,
San Lorenzo, PR) on both sides
(Figure 1D).
Results
A total of 35 patients underwent RGB
percutaneous tracheostomy placement in
a 5-year period. These patients consisted
of 24 men with a mean age of 66 (611) years
(range, 42–88 yr). The mean body mass
index was 34 (68) kg/m2, whereas
16 patients had a body mass index greater
than 35 kg/m2. The majority of patients
(27 of 35) had an American Society of
Anesthesiology classiﬁcation of 4. The
most common respiratory condition
was failure to wean from mechanical
ventilation, followed by tracheal stenosis
and tracheobronchomalacia. The most
commonly recorded indications for RGB-
PDT were complex airway (history of
difﬁcult intubation and/or central airway
obstruction), obesity, and coagulopathy.
The mean procedure time was 32 (610)
minutes, with a median of 33 minutes.
Two patients had bleeding quantiﬁed as
greater than 10 ml, but less than 50 ml.
These bleeding episodes were controlled
with suction and local application of
epinephrine. Two patients experienced
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transient loss of the airway during the
endotracheal tube–rigid bronchoscope
exchange process; however, airway control
was quickly re-established without
associated hypoxemia. No major
periprocedural complications or mortality
was associated with the procedure. All
procedures were considered
successful (Table 1, Table E1).
Discussion
Percutaneous tracheostomy is a well
recognized technique for establishing
a long-term secure airway in the
management of chronic respiratory failure
that often occurs in the ICU patient
population (2, 10, 13–15). Complications
associated with this procedure include
bleeding (external or intratracheal), false
airway passage, perforation of the posterior
wall, placement of high or low tracheal
stomas, displacement of tracheal stents,
and resultant airway obstruction. Flexible
bronchoscopy guidance is commonly
performed to ensure the correct placement
of the tracheostomy and to identify
potential immediate complications (16–19).
However, ﬂexible bronchoscopy-guided
PDT has inherent limitations. These
include inadequate ventilation due to
occlusion of the endotracheal tube,
inadvertent puncture of the cuff or the
ﬂexible bronchoscope, inability to provide
adequate suction in case of massive bleed,
and loss of the airway in the attempt to
show the operator the adequate puncture
site (20–23). In a recent report, these
limitations were circumvented with
suspension laryngoscopy–assisted PDT
(SL-PDT) (24). There has been one
report of rigid bronchoscope guidance in
performing percutaneous tracheostomy
(8). Our study represents the largest case
series to date demonstrating the safety
proﬁle and effectiveness of RBG-PDT
in a highly selected patient population
previously considered to have relative
contraindications for PDT.
Similar to SL-PDT, we ﬁnd that
RBG percutaneous tracheostomy is
most appropriate for patients who are
morbidly obese, or have a complex airway,
coagulopathy, or a history of prior surgery
or radiation to the neck region. Both
procedures (SL-PDT and RBG-PDT)
provide improved visualization of the
extratracheal operative ﬁeld, control for
any endotracheal bleeding, ventilation
during the procedure, and exposure of the
subglottic space and proximal trachea for
accurate tracheostomy insertion and airway
management. The major differences are
the setup of the Pilling-Weck Louie arm
suspension apparatus (Pilling-Weck
Surgical, Fort Washington, PA), the use of
9.0-mm endotracheal tube with a 5-mm 308
Storz rigid endoscope (Karl Stortz
Endoscopy, Tuttlingen, Germany) and
a Dedo laryngoscope (Pilling Surgical,
Horsham, PA) for the SL-PDT (24).
Patient’s body habitus can be
a hindrance to tracheostomy placement
(25). Rigid bronchoscopy not only offers
excellent visibility during the procedure,
but also displaces the trachea anteriorly
to ease the access to the anterior tracheal
wall and improve exposure to the puncture
site. In patients with a complex airway,
the rigid bronchoscope aids in maintaining
a secure airway with the added ability
to provide endobronchial interventions.
A recent study showed that ﬂexible
PDT is safe to perform in patients with
obesity. However, though statistically not
signiﬁcant, the patients who were morbidly
obese did have double the bleeding risk
when compared with the nonobese group
(26). During our initial experience, two
patients experienced transient loss of
the airway while the endotracheal tube
was being exchanged for the rigid
bronchoscope. Both patients were easily
intubated with the rigid bronchoscope
without associated hypoxemia. To prevent
this complication, we modiﬁed the
technique by positioning the tip of the
barrel 5 mm distal to the true vocal cords
in the subglottic space and avoiding
displacement of the rigid barrel as the
endotracheal tube is removed from the
airway. Since this modiﬁcation, we have
not experienced any additional loss of
airway during the procedure.
In those patients who have
uncorrectable coagulopathy, secondary
to liver failure, bone marrow suppression,
or clopidogrel use, the large-caliber
size of the rigid bronchoscope allows for
the use of interventional modalities (suction,
cauterization, epinephrine injections)
in case of excessive bleeding. In our cohort,
two patients had bleeding that was easily
controlled with suction and epinephrine.
In patients with central airway
obstruction, such as in the case of tracheal
or subglottic stenosis, external compression,
or tracheobronchomalacia, the airways
are dilated and stented open by the rigid
bronchoscope. This facilitates the procedure
and prevents potential catastrophic
complications, such as perforation of the
Figure 1. Rigid bronchoscopy–guided–percutaneous dilational tracheostomy in a morbidly obese
patient. (A) Rigid tracheoscope was introduced orally. (B) Exchange of rigid tracheoscope with
endotracheal tube. (C ) Jet ventilation, continuous suction and visual guidance. (D) Tracheostomy
tube was secured in place.
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posterior membranous wall. Those patients
with prior surgeries or radiation to the
neck region may have altered anatomy
due to scar tissue or strictures, thus
requiring better exposure of the anterior
tracheal wall to minimize the risk of
extending the primary stenotic segment. In
our series, we did not observe any increase in
postoperative complications or airway
compromise with concurrent RBG-PDT
and treatment of tracheal obstructive
lesions. In addition, by addressing central
airway lesions with RBG-PDT, we are able to
offer a less invasive (potentially more cost
effective) approach than the surgical option
involving tracheal resection, which is often
avoided in patients with respiratory failure.
There are potential obstacles to
widely adopting this procedure. First,
this procedure requires familiarity with
operating a rigid bronchoscope. Second, it
requires transport of the patient from the
ICU to the operating room. Third, if not
performed by experienced operators, the
airway can be lost during the exchange
process. Fourth, rigid bronchoscopy may
not be adaptive to a bedside procedure
in many institutions (27) (Table 2).
Nevertheless, in the appropriate patient
population, rigid bronchoscopy offers many
advantages. First, it supports the softer
structures, reducing the risk of tracheo-
esophageal puncture and ﬁstula formation.
Second, anterior leverage of the trachea
facilitates tracheal cannulation, especially
in patients who are obese. Third, in the
cases of previously placed tracheal stents,
the rigid bronchoscope provides a large
visual ﬁeld and minimizes the chance for
dislodgement or compression of the stents.
Furthermore, in patients with complex
airways, the rigid bronchoscope provides
a secure airway with excellent views without
risk of cuff puncture or inadvertent
dislodgement of the endotracheal tube
(28). Finally, in patients with coagulopathy,
the rigid bronchoscope allows easy
hemostatic control. Based on these data,
we propose an algorithm for selection of
appropriate patients for RGB-PDT
(Figure 2).
It is important to note that, out of
a total 360 percutaneous tracheostomies
performed in the study period, only
35 patients (,10%) underwent RGB-PDT.
We were very selective, especially with
patients who were morbidly obese.
Contrary to the prior reports on the
signiﬁcant complications of PDT in
patients who were morbidly obese (29),
we observed a 6.5% complication rate
similar to that reported by Heyrosa and
colleagues (30). The issue of poor
anatomical landmarks in the patient who
is morbidly obese is reduced with the use
of rigid bronchoscopy.
The major limitation in our study was
the lack of direct comparison between RBG-
PDT and that of ﬂexible bronchoscopy–
guided PDT. Thus, we are unable to prove
a beneﬁt of using the rigid bronchoscope
in PDT. However, we do provide the setup
and feasibility for future investigations
involving use of the rigid bronchoscope
in a speciﬁed high-risk population. The
superiority in using rigid bronchoscopic
guidance can only be deﬁnitely addressed
with future randomized controlled clinical
trials. Another limitation in our study is the
lack of cost-effectiveness analysis. However,
based on previous studies comparing
Table 1. Characteristics of patients who have undergone rigid bronchoscopy–guided
percutaneous dilational tracheostomy
Male Female Total
Patient Characteristics (n = 24) (n = 11) (n = 35)
Age, yr 66 6 12 67 6 9 66 6 11
BMI, kg/m2 34.2 6 8.6 32.9 6 7.8 34 6 8
ASA score
ASA 3 4 4 8
ASA 4 20 7 27
Mean procedure time, min 30 6 10 36 6 8 32 6 10
Complications
Temporary airway loss 0 2 2
Bleeding . 10 cc 2 0 2
Indications for RGB-PDT
Complex airway 7 7 14
Coagulopathy
BUN . 60, mg/dl 13 2 15
INR . 1.5 9 2 11
Plts , 50,000/ml 3 2 5
Clopidogrel 2 0 2
Combined (>2) 9 1 10
Morbid obesity 10 6 16
Definition of abbreviations: ASA = American Society of Anesthesiologists score; BMI = body mass
index; BUN = blood urea nitrogen; INR = international normalized ratio; Plts = platelets; RBG-PDT =
rigid bronchoscopy–guided percutaneous dilational tracheostomy.
Complex airways: central airway obstruction due to strictures, tracheomalacia, or extrinsic
compression. Coagulopathy: some patients had more than one risk for coagulopathy (i.e.,
a combination of BUN . 60 mg/dl, INR . 1.5, Plts , 50,000/ml, and on Clopidogrel)
Table 2. Advantages and disadvantages of rigid bronchoscopy–guided percutaneous
dilational tracheostomy
Advantages Disadvantages
1. Airway is secured. 1. Unable to provide high PEEP ventilation.
2. Constant visualization of airway,
adequate suction, and ability to
provide therapeutic interventions.
2. Requires experienced operator to
use rigid bronchoscope.
3. Minimizes risk of damage to
bronchoscope.
3. Bronchoscopic intubation can be difﬁcult.
4. Protects posterior wall of the
trachea; tracheal support (especially
in patients with TBM).
4. Not easily done at the bedside
given equipment setup.
5. Facilitates anterior displacement of the
trachea, allowing easier access to the
anterior tracheal wall (especially helpful
in patients with morbid obesity).
Definition of abbreviations: PEEP = positive end-expiratory pressure; TBM = tracheobronchomalacia.
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open and percutaneous tracheostomy, it
is estimated that the percutaneous
tracheostomy had signiﬁcantly lower
wound infection, less unfavorable scarring,
shorter procedural time (by 4.6 min),
and cost approximately $456 USD less
than the open tracheostomy (7, 31). The
third limitation of our current setup
involves transporting of patients to the
operating room. Although prior studies
have reported that transport of critically
ill patients can carry a risk of signiﬁcant
adverse events ranging from 4 to 8% (32),
we did not observe any complications
related to transportation. Fourth, the need
of a well trained bronchoscopist to use rigid
bronchoscopy can limit the availability of
the procedure. However, in the last decade,
rigid bronchoscopy has been gaining
popularity, largely due to the increasing
numbers of practicing interventional
pulmonologists. In the near future, the
procedures involving the use of rigid
bronchoscopy are projected to be more
widespread. Finally, the learning period
for PDT is shorter than for surgical
tracheostomy (33). This may favorably
impact the implementation of RBG-PDT
in patients previously considered at high
risk for percutaneous approach.
Our study offers a single-center
experience with RBG-PDT, not as
a replacement, but, rather, as an adjunct
to the current spectrum of available care,
which includes FBG-PDT, SL-PDT, and
open tracheostomy. To truly demonstrate
the value of RBG-PDT, future randomized
clinical trials are needed to compare the
RBG-PDT to the current standard of care
in terms of safety, indications, and cost
effectiveness. In the largest case series
to date, we demonstrate that RBG-PDT
is safe and effective when performed
by experienced bronchoscopists in
a population of high-risk patients who
are otherwise not considered good
candidates for standard PDT. As an
intermediate step between percutaneous
and surgical tracheostomy, we propose
a strategy to incorporate rigid bronchoscope
use in PDT for a selected patient population
with morbid obesity, complex
airways, and/or coagulopathy. n
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